Tirzepatide Prescribing at MAYFORD HOUSE SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
464
Total Quantity
468
NHS Cost
£42.2K
vs National Avg
+138.9%
MAYFORD HOUSE SURGERY prescribed 464 items of Tirzepatide over the last 12 months at a cost of £42,245 to the NHS. This is 138.9% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
7
Jul 2026
16
Jul 2026
20
Jul 2026
27
Jul 2026
32
Jul 2026
48
Jul 2026
48
Jul 2026
44
Jul 2026
50
Jul 2026
65
Jul 2026
51
Jul 2026
56
Prescribing Details
| Total Items | 464 |
|---|---|
| Total Quantity | 468 |
| Total NHS Cost | £42,245 |
| Presentations | 7 different forms |
| vs National Average | +138.9% |
Tirzepatide Prescribing Comparison
| This practice | 464 items |
|---|---|
| National average per practice | 194 items |
| Difference | +138.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.